ArticleJournal of medicine and life2026
Anxiety and depressive symptoms in patients with acute ischaemic stroke and cognitive dysfunction: a retrospective single-center study.
Article in Journal of medicine and life, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anxiety and depressive symptoms may coexist with cognitive dysfunction after stroke. This study characterized their frequency and severity during acute stroke hospitalization in patients with documented cognitive dysfunction. We conducted a retrospective, single-center study of 95 adults with acute ischaemic stroke (AIS) and cognitive dysfunction in Romania during 2024-2025. Anxiety and depressive symptoms were derived from neuropsychological conclusions and classified as absent/minimal, mild, moderate, or severe. In the main analysis, "elements" and the depression-specific "tendency" were classified as absent/minimal, while hybrid descriptors were assigned to the adjacent higher category. Sensitivity analyses examined alternative allocations. Associations were assessed using the chi-square, Fisher's exact, or Kruskal-Wallis test. Anxiety severity was available for 94 patients and was distributed as follows: 26.6% absent/minimal, 16.0% mild, 50.0% moderate, and 7.4% severe. The severe category derived from "moderate-severe" descriptors. Overall, 73.4% had anxiety of at least mild severity. Depression severity was available for 86 patients, distributed as 74.4% absent/minimal, 17.4% mild, 7.0% moderate, and 1.2% severe; 25.6% had depression of at least mild severity. Under alternative low-level classifications, the anxiety-depression difference at the at-least-mild threshold narrowed from 47.8 to 28.1 and 9.0 percentage points. Anxiety remained more frequent. Sex was associated with both severity distributions. These proportions reflect documented severity rather than prevalence estimates derived from a uniform standardized instrument. Anxiety was more frequently documented and more often reached moderate-or-greater severity than depression. Routine neuropsychological conclusions may provide information on the affective profile during this phase of care. Longitudinal studies should examine affective, cognitive, and functional trajectories during recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.